Johnson & Johnson (NYSE:JNJ) ~ Analyst Moves: JNJ, LNKD, INTC

[at Forbes] – This morning, Credit Suisse increased its price target on shares of Johnson & Johnson (JNJ) to $94 as growth from Invokana is expected to be better than originally expected. In . . . → Read More: Johnson & Johnson (NYSE:JNJ) ~ Analyst Moves: JNJ, LNKD, INTC Similar posts: Stock Update: Bank of America Corporation (NYSE:BAC) – Bank of America moves $19B 401(k) plan in-house, Reuters says Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in Credit Suisse 2013 Health Care Conference Johnson & Johnson (NYSE:JNJ) – Solid Earnings, But Momentum Has Pushed Up Expectations